Kelly Financial Services’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Kelly Financial Services’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-17	Closed	-$3.69K	–	676
2021 Q1	$3.69K	Hold	17	–	–	﹤0.01%	443
2020 Q4	$1.96K	Hold	17	–	–	﹤0.01%	462
2020 Q3	$1.66K	Hold	17	–	–	﹤0.01%	449
2020 Q2	$2.09K	Sell	17 -28	-62%	-$3.18K	﹤0.01%	426
2020 Q1	$3.94K	Sell	45 -1	-2%	-$106	﹤0.01%	323
2019 Q4	$4.81K	Hold	46	–	–	﹤0.01%	308
2019 Q3	$5.29K	Hold	46	–	–	﹤0.01%	286
2019 Q2	$7.93K	Buy	46 +28	+156%	+$4.84K	0.01%	246
2019 Q1	$3.03K	Buy	+18	New	+$2.68K	﹤0.01%	343

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Kelly Financial Services's GWPH Position: Q2 2021 in Review

Kelly Financial Services sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 17 shares — an estimated $3.69K sold.

Kelly Financial Services first reported a position in GWPH in Q1 2019 and held it in 9 quarters. The position peaked at $7.93K in Q2 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Kelly Financial Services reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Kelly Financial Services sold 17 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $3.69K.
Kelly Financial Services first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2019 and held it in 9 quarters.
Kelly Financial Services's GW Pharmaceuticals Plc American Depositary Shares position peaked at $7.93K in Q2 2019.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Kelly Financial Services's 13F filing for Q2 2021, filed 17 Jul 2024.